MOTTOLA FRANK (Sr VP, Quality, GMP Oper. & IT) sold 24.4% of their position (5K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $229.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2025ACC: 0001804567-25-000006
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
-5K
Net shares
Net seller
$229.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$39.40
Trade value
$197K
% of position
32.3%
9/12/2025
15.50K→20.50K
Common Stock
Direct
Shares
−5K
Price / share
$45.87
Trade value
$229.35K
% of position
24.4%
9/12/2025
20.50K→15.50K
Total
Net shares
+0.00
Net value
-$32.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2025 | M · Option Exercise | +5K | $39.40 | $197K | 32.3% | 15.50K | 20.50K |
| Common Stock Direct | 9/12/2025 | S · Sale | −5K | $45.87 | $229.35K | 24.4% | 20.50K | 15.50K |
| Total | +0.00 | -$32.35K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
39.40
Held after
5K
Exercisable
—
9/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock5K shares | 9/12/2025 | M · Option Exercise | −5K | 39.40 | — | 5K |